2015 - Fellow of the Australian Academy of Health and Medical Science
Stroke, Internal medicine, Surgery, Randomized controlled trial and Cardiology are his primary areas of study. His research integrates issues of Physical therapy and Tissue plasminogen activator in his study of Stroke. His Physical therapy study combines topics in areas such as Vascular disease and Emergency medicine.
As part of his studies on Internal medicine, Geoffrey A. Donnan often connects relevant subjects like Placebo. His Surgery research is multidisciplinary, incorporating perspectives in Clinical trial, Desmoteplase, Intensive care medicine, Meta-analysis and Intracerebral hemorrhage. His Randomized controlled trial research incorporates elements of Translational research and Brain ischemia.
His primary scientific interests are in Stroke, Internal medicine, Cardiology, Surgery and Thrombolysis. His work carried out in the field of Stroke brings together such families of science as Physical therapy, Randomized controlled trial, Intensive care medicine and Clinical trial. The Brain ischemia, Modified Rankin Scale, Odds ratio and Aspirin research he does as part of his general Internal medicine study is frequently linked to other disciplines of science, such as Clinical neurology, therefore creating a link between diverse domains of science.
Geoffrey A. Donnan combines subjects such as Placebo, Intracerebral hemorrhage and Risk factor with his study of Surgery. The concepts of his Thrombolysis study are interwoven with issues in Anesthesia, Magnetic resonance imaging, Fibrinolytic agent, Perfusion scanning and Tissue plasminogen activator. His study in Magnetic resonance imaging is interdisciplinary in nature, drawing from both Nuclear medicine and Penumbra.
His scientific interests lie mostly in Stroke, Internal medicine, Thrombolysis, Cardiology and Emergency medicine. His Stroke research integrates issues from Odds ratio and Randomized controlled trial, Surgery. He has included themes like Physical therapy and Clinical trial in his Randomized controlled trial study.
His research on Internal medicine frequently connects to adjacent areas such as Placebo. The Thrombolysis study which covers Triage that intersects with Prehospital thrombolysis. His research investigates the connection between Cardiology and topics such as Magnetic resonance imaging that intersect with problems in Nuclear medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
R Altman;L Carreras;R Diaz;E Figueroa.
Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)
Werner Hacke;Markku Kaste;Cesare Fieschi;Rüdiger von Kummer.
The Lancet (1998)
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials
Werner Hacke;Geoffrey Donnan;Cesare Fieschi;Markku Kaste.
The Lancet (2004)
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials
Mayank Goyal;Bijoy K. Menon;Wim H. van Zwam;Diederik W. J. Dippel.
The Lancet (2016)
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials.
Kennedy R Lees;Erich Bluhmki;Rüdiger von Kummer;Thomas G Brott.
The Lancet (2010)
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
Jonathan Emberson;Kennedy R Lees;Patrick Lyden;Lisa Blackwell.
The Lancet (2014)
Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial
Jörg Ederle;Joanna Dobson;Joanna Dobson;Roland L. Featherstone;Leo H. Bonati;Leo H. Bonati.
The Lancet (2010)
1,026 Experimental treatments in acute stroke
Victoria E O'Collins;Malcolm R Macleod;Geoffrey A Donnan;Laura L Horky.
Annals of Neurology (2006)
Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis
Jeffrey L. Saver;Mayank Goyal;Aad van der Lugt;Bijoy K. Menon.
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke
Ralph L. Sacco;Hans-Christoph Diener;Salim Yusuf;Daniel Cotton.
The New England Journal of Medicine (2008)
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: